LOTEPREDNOL ETABONATE
| Brand name | LOTEMAX SM |
|---|---|
| Active ingredient | LOTEPREDNOL ETABONATE |
| Strength | 0.38% |
| Dosage form | GEL |
| Route | OPHTHALMIC |
| Modality | Small molecule |
| FDA approval | February 2019 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 10596107 | December 2036 | product |
| 11534395 | January 2036 | product |
| 12589069 | January 2036 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.